ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,222Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 487

$463K Total Retail Price of All Prescriptions

Rank: 44 out of 487

402 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 402 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 402 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 7,861 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
LISINOPRIL 400 354 1 5
LEVOTHYROXINE SODIUM 349 306 2 1
SIMVASTATIN 334 309 3 4
OMEPRAZOLE 295 234 4 2
METFORMIN HCL 287 268 5 8
HYDROCHLOROTHIAZIDE 238 226 6 9
HYDROCODONE-ACETAMINOPHEN 231 185 S3 7 3
AMLODIPINE BESYLATE 222 211 8 6
WARFARIN SODIUM 190 173 9 11
ZOLPIDEM TARTRATE 187 120 10 14
CITALOPRAM HBR 167 144 11 12
METOPROLOL SUCCINATE 157 155 12 15
FUROSEMIDE 154 138 13 7
ATORVASTATIN CALCIUM 153 137 14 18
LOSARTAN POTASSIUM 127 108 15 16
EVISTA 126 126 16 110
LOVASTATIN 123 118 17 30
POTASSIUM CHLORIDE 120 119 18 10
TRAMADOL HCL 107 89 19 19
METOPROLOL TARTRATE 105 93 20 17
DONEPEZIL HCL 98 97 21 38
RANITIDINE HCL 97 94 22 39
GLYBURIDE 96 96 R 23 132
FLUOXETINE HCL 89 80 24 28
DIGOXIN 84 80 25 47
SERTRALINE HCL 75 63 26 21
TAMSULOSIN HCL 70 43 27 25
ALENDRONATE SODIUM 70 69 27 27
TRIAMTERENE-HYDROCHLOROTHIAZID 70 68 27 122
ACTOS 67 67 30 88
TRAZODONE HCL 65 61 31 22
ALLOPURINOL 63 60 32 29
SPIRONOLACTONE 62 61 33 43
ATENOLOL 62 61 33 23
OLANZAPINE 61 61 35 73
NAMENDA 60 60 36 53
LANTUS 57 43 37 44
GABAPENTIN 57 41 37 13
CYCLOBENZAPRINE HCL 51 23 R 39 64
INDAPAMIDE 50 43 40 200
LANTUS SOLOSTAR 50 32 40 72
FLUTICASONE PROPIONATE 50 42 40 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.